This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As medical devices evolve and become more sophisticated, we are seeing a trend toward specialization. Building customized solutions for specialized disease states creates a nimbleness to respond to new conditions and develop a platform uniquely suited for that condition. It will become commonplace to see devices that break new ground.
To bring cross-agency clinical leaders together, the FDA should establish a Center of Excellence for Rare Diseases. This would bring together specialized staff and resources from multiple review divisions to leverage their expertise about different bodily systems, trial designs, pharmacology, and other specialized fields.
If so, it is important to understand the regulatory requirements of the FDA. Do you know the FDA is the Food and Drug Administration? It is essential to understand the FDA’s definition of a medical device. Let’s see FDA regulations for medical device training.
GOOD MORNING: The FDA is taking a scientific approach to evaluating direct-to-consumer (DTC) drug advertising, focusing on measuring consumer perceptions of the information presented in ads. Since when is consumer behavior ever scientific? ” So, are we supposed to believe that better images in DTC ads lead to patients asking for an Rx?
an innovator in the field of orthopedic surgical robots, today announced that its TMINI Miniature Robotic System has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with implants from three additional implant manufacturers. THINK Surgical, Inc., Are you hiring?
The US Food and Drug Administration (FDA) has granted approval for Amylyx Pharmaceuticals’ Relyvrio (sodium phenylbutyrate and taurursodiol) to treat adult patients with amyotrophic lateral sclerosis (ALS). The FDA approval is based on findings from the multicentre Phase II CENTAUR clinical trial that enrolled 137 ALS patients.
The US Food and Drug Administration (FDA) has approved expanded labelling for Cumberland Pharmaceuticals’ Caldolor therapy to include use in infants. Caldolor has already obtained FDA approval for pre-operative administration.
Despite the potential of SaMD/DTx tools, navigating the FDA’s regulatory requirements can be daunting, especially for pre-revenue digital health developers with limited resources. Compliance can be time-consuming and resource-intensive, requiring specialized skills for clinical studies and evidence generation for validation.
Food and Drug Administration (FDA) granted marketing authorization of the MISHA Knee System, an implantable shock absorber (ISA) for the knee. Chief, Hip and Knee Division of Sports Medicine Institute, Hospital for Special Surgery in New York. Moximed is based in Fremont, California. Are you hiring?
To enhance digital ad performance, pharma marketers can utilize platforms like eHealthcare Solutions , which specializes in pharma advertising solutions tailored for reaching HCPs and patients. Marketers must ensure that their campaigns adhere to FDA, HIPAA, and GDPR guidelines to avoid legal complications.
Best For: Targeting verified HCPs in a compliant and specialized environment. Follow FDA and Regulatory Guidelines Ensure all PPC ads adhere to FDA, EMA, or MHRA regulations. Following FDA regulations, using fair balance messaging, and targeting verified HCPs helps maintain compliance.
With their specialized expertise, they understand the complex regulatory environment and can craft campaigns that resonate with your target audience while staying compliant. Industry Experience and Proven Track Record Does the company specialize in pharmaceutical marketing, or is healthcare just one of many industries they serve?
Importantly, across all 11 patients between the ages of 1 and 11 who were dosed with RGX-202, there have been no serious adverse events or adverse events of special interest, such as drug-induced liver injury, which was the cause death for the 16-year-old boy after being treated with Elevidys.
Food and Drug Administration (FDA) clearance for the company’s FreedomFlow® Peripheral Guidewire. Co-founded by Dr. Jihad Mustapha and Dr. Fadi Saab, ACV Centers has a special concentration on treating peripheral artery disease and the complications of critical limb ischemia. Cardio Flow, Inc., Are you hiring?
For advanced social media advertising solutions, platforms like eHealthCare Solutions offer specialized tools for reaching HCPs and targeted pharma audiences. Social media analytics should always align with FDA, HIPAA, and GDPR regulations to protect patient privacy and ensure ethical marketing practices.
market with a breakthrough FDA-Class II medical device, TargetCool. ” TargetCool was created by award-winning South Korean mechanical engineer, Dr. Gun-Ho Kim, who specializes in thermal engineering. Recens, Inc. “We truly believe that TargetCool will change the face of cooling,” Dr. Kim stated. Are you hiring?
As part of the new deals, BioNTech will have commercial rights to the ADCs worldwide, excluding mainland China, the Hong Kong special administrative region and the Macau special administrative region. The agreements also include the manufacturing and commercialisation of the two assets, including DB-1303 and DB-1311, across the globe.
The US Food and Drug Administration (FDA) granted final approval to the therapy in May 2023. LUMRYZ represents a new generation of oxybate treatment that the FDA deems clinically superior to twice-nightly oxybate treatments. LUMRYZ is an extended-release formulation of sodium oxybate, indicated to be taken once at bedtime.
Experts in the management of SARS-CoV-2 educate on CDC and FDA recommendations for approaching administration of booster vaccines, including those for special patient populations.
After two years of pandemic fatigue, healthcare trust is at an all-time low, according to Edelman’s Trust Barometer Special Report on Trust in Healthcare. Wegovy, for example, has been approved by the FDA to treat obesity and excess weight – conditions that can lead to type 2 diabetes and prediabetes.
Strict guidelines from the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) require marketers to ensure transparency and accuracy in all communications. FDA Guidelines and Promotional Review Committees Understanding FDA regulations is critical for all pharma marketing professionals.
The US Food and Drug Administration (FDA) has granted approval for Azurity Pharmaceuticals’ Konvomep (omeprazole and sodium bicarbonate for oral suspension) to treat active benign gastric ulcer. A pharmaceutical firm, Azurity focuses on developing new products for the special requirements of overlooked patients.
Sodium oxybate — which in the late 1980s was marketed to bodybuilders and then became known as GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. In 2020, the FDA-approved indication was expanded to include those patients who suffer from cataplexy.
Example: If promoting Jardiance for diabetes management, focus on unique selling points like proven efficacy and FDA approval. Ensure your ads comply with FDA guidelines. Tools to Use: Google Analytics, HubSpot, or even specialized healthcare marketing platforms. Adding a sense of urgency (“Learn more today!”)
The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticals’ pharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. It is specialised in innovative processes for producing difficult-to-manufacture speciality and generic drugs.
Despite the potential of SaMD/DTx tools, navigating the FDA’s regulatory requirements can be daunting, especially for pre-revenue digital health developers with limited resources. Compliance can be time-consuming and resource-intensive, requiring specialized skills for clinical studies and evidence generation for validation.
FDA clearance for distribution in the United States. Specializing in digital therapeutics for respiratory care, the company is committed to delivering affordable and interoperable lung health solutions. FDA-cleared, portable digital spirometer, alveoair® is part of alveofit’s ecosystem. and emerging economies.
Businesses like Infuse Med know the need of following laws such FDA, HIPAA, and GDPR so that their apps not only operate well but also satisfy the necessary legal criteria for medical device safety and data protection. Medical device apps can be used for a wide array of healthcare functions, such as: Tracking patient metrics (e.g.,
In the medical device world, the FDA and other regulatory bodies limit how we can promote many of our products. Marketo – A company that specializes in marketing automation software. Medmarc – An insurance company that specializes in insuring life science companies. For example, today I watched a webinar on video marketing.
Invictus Medical announced today that the culmination of their De Novo application to the FDA for its Neoasis ® incubator-based active noise control (ANC) device has resulted in a clearance-for-use declaration by the FDA. Invictus Medical is a privately held company. Are you hiring?
The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow® in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions. The US Food and Drug Administration has approved the use of iTFlow® in blood flow analysis.
Food and Drug Administration (FDA) for continuous neonatal and infant monitoring for babies born of any gestational age to infants of 2 years at the International Maternal Newborn Health Conference in Cape Town, South Africa. The vast majority of medical devices used in pediatrics are not FDA-cleared or designed for children.
a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is pleased to announce a significant milestone following receipt of FDA Investigational Device Exemption (IDE) approval to conduct a staged pivotal clinical trial for its Duett Vascular Graft System in the United States. Are you hiring?
This layer of specialized endothelium significantly restricts which drug molecules can enter the brain, normally greatly limiting treatment options for patients with brain-based disease. CraniUS , a medtech company based in Baltimore, has developed the NeuroPASS drug delivery system.
eCential Robotics, a French growth MedTech company that designs and produces a system unifying 2D/3D imaging, surgical navigation and robotics, announced FDA 510(k) clearance of its 3D imaging, navigation and robotics guidance system, securing the penetration of its unified robotic platform in the United States. Securing the U.S.
The agency provides best-in-class marketing and advertising, media strategy and purchasing, medical affairs and medical communications, value and market access services, as well as enterprise omnichannel enablement among its specialized offerings. Peregrine Market Access has been nationally recognized on the Inc.
Speciality pharmaceutical company SERB Pharmaceuticals has acquired exclusive US rights for bentracimab from SFJ Pharmaceuticals. In partnership with SERB Pharmaceuticals, the company will also file a biologics licence application (BLA) to the US Food and Drug Administration (FDA) later this year.
Ketarx will be marketed under the FDA-approved label of ketamine and in dosages that include 10mg/ml, 50mg/ml and 100mg/ml, with the option to boost the concentration and ready-to-administer applications. Ketamine is currently on the FDA’s drug shortage list. Ketarx will then be commercially launched in the second quarter.
While it’s unsurprising that patients flock to these cheaper alternatives to treat common conditions, generic medications aren’t as accessible for specialized conditions, which gives pharma marketers an opportunity to drive scripts where the market is less crowded. References: 1.
Notably, this rulemaking does not propose to implement the “special registration” for telemedicine providers the DEA has been promising since the Ryan Haight Act passed in 2009. Instead, it would create a new regulatory category of the “practice of telemedicine.” The proposed recordkeeping obligations listed in proposed 21 CFR §1304.03(c)(i)-(k)
This aligns well with newly-issued FDA draft guidance on Computer Software Assurance, which states: “Because the computer software assurance effort is risk-based, it follows a least-burdensome approach, where the burden of validation is no more than necessary to address the risk.” FDA, 2022. . About the authors.
The board of directors of Myovant constituted a special committee of independent directors including its audit committee members to assess the proposal. The special committee decided that the deal substantially undervalues Myovant and is not in the firm’s or its minority shareholders’ best interests.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content